Anebulo Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Anebulo Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2021 to 2024.
  • Anebulo Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2023 was -$2.73M, a 34.1% decline year-over-year.
  • Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$8.09M, a 16.4% increase from 2023.
  • Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$9.68M, a 78.1% decline from 2022.
  • Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$5.44M, a 11.6% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$8.09M +$1.59M +16.4% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-25
2023 -$9.68M -$4.25M -78.1% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-25
2022 -$5.44M -$566K -11.6% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-22
2021 -$4.87M Jul 1, 2020 Jun 30, 2021 10-K 2022-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.